A wonderful way to start our day
http://www.medicalnewstoday.com/releases/235543.php
I loved reading:
We're encouraged that the survival advantages found in this study have been maintained and continue to be significant," said Slamon, director of clinical/translational research at UCLA's Jonsson Comprehensive Cancer Center. "I believe there's room for even further improvement."
Slamon said this is the first time that overall survival has been measured this far out a little more than five years - in this population of breast cancer patients.
For some of the new members who have recently joined, (Denise, Scared Silly, Just Starting & Terrified, Clairex, Meo, Stefanie S, Norkdo, Bunty, Kellennea) hopefully this will offer some calm
for you.
Jean
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006
Last edited by Jean; 10-07-2011 at 06:12 AM..
|